Worked as health economist in NHS: unit, district and PCT; and private sector as senior global health economist to AstraZeneca pharmaceuticals. Health Economics Advisor to the National Diabetic Retinopathy Network and economics advisor to the Department of Health’s National Screening Committee’s Ante Natal Sub Group. Reviewer for government bodies and research councils; nationally and internationally. Primary objective for her research: applied economic evaluation.
Published and presented widely in the field of clinical and economic evaluation including articles in the BMJ, Rheumatology, International Journal of Health Planning and Management, Journal of Epidemiology and Community Health, and the British Journal of Surgery.